ArticlePharmacoEconomics2014

Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada.

Anita J Brogan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.